Willy Roth

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects

Joachim Stangier, Karin Rathgen, Hildegard Stähle et al. · British Journal of Clinical Pharmacology · 2007 · 884 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

The Metabolism and Disposition of the Oral Direct Thrombin Inhibitor, Dabigatran, in Humans

Stefan Blech, Thomas Ebner, Eva Ludwig-Schwellinger et al. · Drug Metabolism and Disposition · 2007 · 682 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Fully automated high-performance liquid chromatography

Willy Roth, K Beschke, R Jauch et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1981 · 199 citations

Pharmacy, Chemistry, Analytical Chemistry +11

PREDOMINANT CONTRIBUTION OF OATP1B3 TO THE HEPATIC UPTAKE OF TELMISARTAN, AN ANGIOTENSIN II RECEPTOR ANTAGONIST, IN HUMANS

Naoki Ishiguro, Kazuya Maeda, Wataru Kishimoto et al. · Drug Metabolism and Disposition · 2006 · 177 citations

Medicine, Biochemistry, Pharmacology +15

Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate, an Oral Direct Thrombin Inhibitor, Are Not Affected by Moderate Hepatic Impairment

Joachim Stangier, Hildegard Stähle, Karin Rathgen et al. · The Journal of Clinical Pharmacology · 2008 · 173 citations

Pharmacy, Pharmacokinetics, Pharmacology +16